Item 5.07 Submission of Matters to a Vote of Security Holders

On November 22, 2021, Tauriga Sciences, Inc. (OTCQB stock symbol: TAUG, the "Company") held a special meeting (the "Special Meeting") of its shareholders. At the Special Meeting, there were 197,827,406 shares of common stock represented in person or by proxy of the 290,421,214 shares of common stock entitled to be cast, constituting a quorum. Of the shares of common stock cast, a majority of such shares needed to vote in favor of Proposal 1 to be approved were cast; and with respect to Proposal 2, a plurality of the shares needed to elect each of the director nominees set forth in the Proxy Statement were cast.

The matters voted on at the Special Meeting and the results of the respective votes were as follows:

Proposal 1. Approve an amendment to our Articles of Incorporation to (collectively, "Proposal 1") to: (i) allow for consideration of the change of the name of our Company to Sublingual Technologies Inc.; (ii) to allow, including under the Florida Business Corporations Act Section 607.1002, action by our Board of Directors to affect a change in the name of our Company without shareholder approval; and (iii) to increase the total number of authorized shares of common stock, par value $.00001 per share ("Common Stock") from 400,000,000 to 750,000,000 shares;.





     FOR            AGAINST          ABSTAIN       BROKER NON-VOTES
  169,838,815       21,158,545       6,830,046

Proposal 2. Election as director of the following nominees as specified in the Proxy Statement ("Proposal 2"):





      NAME              FOR            AGAINST         ABSTAIN        BROKER NON-VOTES
  Seth M. Shaw       119,948,084       8,353,509       2,535,070          66,990,743
Thomas J. Graham     123,273,157       4,671,508       2,891,998          66,990,743
James V. Rosati      123,396,516       4,166,475       3,273,672          66,990,743
Chris Sferruzzo      123,563,819       4,133,746       3,139,098          66,990,743

Proposal 3. The shareholders approved the proposal to adjourn the Special Meeting, if necessary, including to solicit additional proxies in the event that there were not sufficient votes to attain quorum or to approve any of the foregoing proposals.





     FOR            AGAINST          ABSTAIN       BROKER NON-VOTES
  183,374,051       10,193,613       4,259,742

Item 7.01 Regulation FD Disclosure.

On November 23, 2021, the Company issued a press release announcing the voting results of the special meeting of its shareholders. The press release is attached hereto as Exhibit 99.1.

The press release attached hereto as Exhibit 99.1 is being furnished pursuant to Item 7.01 and will not be deemed to be filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise be subject to the liabilities of that section, nor will it be deemed to be incorporated by reference in any filing under the Securities Act or the Exchange Act.

Item 9.01 Exhibits Statements and Exhibits





(d) Exhibits



  Exhibit Number   Description

  99.1               Press release, dated November 23, 2021
  104              Cover Page Interactive Data File (embedded within the Inline
                   XBRL document)

© Edgar Online, source Glimpses